| Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial SEAQA Malaria The Lancet 366 (9487), 717-725, 2005 | 1285* | 2005 |
| Vivax malaria: neglected and not benign RN Price, E Tjitra, CA Guerra, S Yeung, NJ White, NM Anstey The American journal of tropical medicine and hygiene 77 (6 Suppl), 79, 2007 | 1068 | 2007 |
| Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number RN Price, AC Uhlemann, A Brockman, R McGready, E Ashley, L Phaipun, ... The Lancet 364 (9432), 438-447, 2004 | 1046 | 2004 |
| Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia E Tjitra, NM Anstey, P Sugiarto, N Warikar, E Kenangalem, M Karyana, ... PLoS medicine 5 (6), e128, 2008 | 783 | 2008 |
| A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010 PW Gething, IRF Elyazar, CL Moyes, DL Smith, KE Battle, CA Guerra, ... Public Library of Science 6 (9), e1814, 2012 | 682 | 2012 |
| Effects of artemisinin derivatives on malaria transmissibility RN Price, F Nosten, C Luxemburger, FO Ter Kuile, L Paiphun, ... The Lancet 347 (9016), 1654-1658, 1996 | 646 | 1996 |
| Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study F Nosten, M Van Vugt, R Price, C Luxemburger, KL Thway, A Brockman, ... The Lancet 356 (9226), 297-302, 2000 | 642 | 2000 |
| The pathophysiology of vivax malaria NM Anstey, B Russell, TW Yeo, RN Price Trends in parasitology 25 (5), 220-227, 2009 | 547 | 2009 |
| Factors contributing to anemia after uncomplicated falciparum malaria RN Price, JA Simpson, F Nosten, C Luxemburger, L Hkirjaroen, F ter Kuile, ... The American journal of tropical medicine and hygiene 65 (5), 614, 2001 | 522 | 2001 |
| New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance RN Price, NM Douglas, NM Anstey Current opinion in infectious diseases 22 (5), 430-435, 2009 | 447 | 2009 |
| A novel multiple-stage antimalarial agent that inhibits protein synthesis B Baragaña, I Hallyburton, MCS Lee, NR Norcross, R Grimaldi, TD Otto, ... Nature 522 (7556), 315-320, 2015 | 440 | 2015 |
| Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis RN Price, L Von Seidlein, N Valecha, F Nosten, JK Baird, NJ White The Lancet infectious diseases 14 (10), 982-991, 2014 | 409 | 2014 |
| “Asymptomatic” malaria: a chronic and debilitating infection that should be treated I Chen, SE Clarke, R Gosling, B Hamainza, G Killeen, A Magill, ... PLoS medicine 13 (1), e1001942, 2016 | 390 | 2016 |
| The pfmdr1 Gene Is Associated with a Multidrug-Resistant Phenotype in Plasmodium falciparumfrom the Western Border of Thailand RN Price, C Cassar, A Brockman, M Duraisingh, M Van Vugt, NJ White, ... Antimicrobial agents and chemotherapy 43 (12), 2943-2949, 1999 | 379 | 1999 |
| A research agenda for malaria eradication: vector control malERA Consultative Group on Vector Control PLoS medicine 8 (1), e1000401, 2011 | 373* | 2011 |
| Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study KE Battle, TCD Lucas, M Nguyen, RE Howes, AK Nandi, KA Twohig, ... The Lancet 394 (10195), 332-343, 2019 | 362 | 2019 |
| Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multidrug-Resistant Plasmodium falciparum Malaria RN Price, AC Uhlemann, M van Vugt, A Brockman, R Hutagalung, S Nair, ... Clinical Infectious Diseases 42 (11), 1570-1577, 2006 | 356 | 2006 |
| Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. RIC Price, M van Vugt, L Phaipun, C Luxemburger, J Simpson, ... The American journal of tropical medicine and hygiene 60 (4), 547-555, 1999 | 351 | 1999 |
| The relationship between age and the manifestations of and mortality associated with severe malaria AM Dondorp, SJ Lee, MA Faiz, S Mishra, R Price, E Tjitra, M Than, Y Htut, ... Clinical Infectious Diseases 47 (2), 151-157, 2008 | 345 | 2008 |
| Impaired nitric oxide bioavailability and l-arginine–reversible endothelial dysfunction in adults with falciparum malaria TW Yeo, DA Lampah, R Gitawati, E Tjitra, E Kenangalem, YR McNeil, ... The Journal of experimental medicine 204 (11), 2693-2704, 2007 | 328 | 2007 |
Nicholas AnsteyMenzies School of Health Research在 menzies.edu.au 的电子邮件经过验证
